Primrose Bio was proud to participate in TIDES USA 2025, held May 19–22 in our hometown of San Diego. The event brought together leaders in oligonucleotide and peptide development, and we were excited to highlight how our enzymatic technologies are driving innovation in nucleic acid manufacturing.
On May 21, Helge Zieler, PhD, presented:
“Meeting the Manufacturing Needs of Nucleic Acids Used in Modern Medicines: Novel and Efficient Enzymatic Processes for mRNA and Oligonucleotide Synthesis,” offering a closer look at Primrose’s cutting-edge solutions.
Two scientific posters also showcased key advances:
- Poster #86 – Daniel Olson, PhD: “Prima RNApol™ ExTend: Rewriting the Rules of Long mRNA Manufacturing”
- Poster #83 – Maite Arrizubieta Celaya, PhD: “Advancing mRNA Therapeutics with High-Performance RNA Polymerases”
